OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 4, 2017

Primary Completion Date

October 31, 2018

Study Completion Date

November 30, 2018

Conditions
Lung NeoplasmsLung Cancer
Interventions
DRUG

OTL38 for Injection

Folate analog ligand conjugated with an indole cyanine-like green dye as a solution in vials containing 3 mL at 2 mg/mL

DEVICE

Near infrared camera imaging system

Near infrared camera imaging system

PROCEDURE

Endoscopic or Thoracic Surgery

Endoscopic or Thoracic Surgery

Trial Locations (6)

15232

University of Pittsburgh Medical Center, Pittsburgh

19104

University of Pennsylvania, Philadelphia

44195

Cleveland Clinic, Cleveland

77030

MD Anderson Cancer Center, Houston

02215

Beth Israel Deaconess Medical Center, Boston

2333 ZA

Leiden University Medical Center, Leiden

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medelis Inc.

INDUSTRY

lead

On Target Laboratories, LLC

INDUSTRY